Clinical trial Recruiting at 1 site Observational Ages 8 to 99

Evaluating seizures in patients with brain tumors

Official title: Tumor Related Epilepsy

Run by National Institutes of Health Clinical Center (CC) · NCT02639325 · Data updated 2026-11-12

This study looks at how brain tumors that cause seizures affect people aged 8 and older, and whether surgery can help reduce those seizures and improve thinking skills.

Quick facts

Study typeObservational
Ages8 Years to 99 Years
SexAll
Enrollment100 (estimated)
SponsorNational Institutes of Health Clinical Center (CC)
NIH
Drugs / interventionschemotherapy, radiation
Locations1 site (Bethesda, Maryland)
StatusRecruiting
StartedJanuary 26, 2016
Main results expectedJuly 1, 2032
Study endsJuly 1, 2032
Registry record updatedNovember 9, 2026
Trial IDNCT02639325 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 8 and older with a confirmed diagnosis of a brain tumor and associated seizures.

Probably not a fit

Patients who do not have a brain tumor or those whose seizures are not related to a brain tumor may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on individuals aged 8 and older who have brain tumors associated with seizures, known as tumor-related epilepsy. The research aims to evaluate the natural history of this condition and the impact of surgical treatment on seizure outcomes. Participants will undergo a thorough medical evaluation, including neurological exams and cognitive assessments, to gather data on their condition before and after surgery. The study also seeks to explore the relationship between tumor characteristics, surgical resection, and changes in seizure activity and cognitive function.

Why it matters

Potential benefit: If successful, this study could lead to improved surgical outcomes and reduced seizure frequency for patients with brain tumors.

How similar studies have gone: Other studies have shown promising results in surgical interventions for tumor-related epilepsy, indicating potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
* INCLUSION CRITERIA:

To be eligible for entry into the study, a candidate must meet all the following criteria:

* Be 8 years of age or older.
* Have solitary primary or recurrent brain tumor with associated seizures. Brain tumor may be diagnosed radiologically. Associated seizures are defined as those with activity starting within three months of radiologic diagnosis of the primary or recurrent tumor. In cases when the timing of seizure activity is unclear with respect to the timing of diagnosis, seizures will be considered associated with the tumor if seizure semiology is consistent with that location. Ongoing seizures are not required. Patients can be included if they have had a single previous seizure. Patients who have not experienced seizures after institution of anti-convulsant therapy are not excluded.

EXCLUSION CRITERIA:

Candidates will be excluded if they:

-At the time of enrollment, lack consent capacity due to cognitive impairment that would make them incapable of understanding the explanation of the procedures in this study. Cognitive capacity to consent will be determined at the time of enrollment. Patients with mental disorders or those patients who are cognitively impaired yet still retain consent capacity will not be excluded. Children may be enrolled if there is a parent or guardian able to consent on their behalf.

Where it's running

  • National Institutes of Health Clinical Center
    Bethesda, Maryland, United States
    Recruiting

Study contacts

  • Principal investigator: Kareem A Zaghloul, M.D. — National Institute of Neurological Disorders and Stroke (NINDS)
  • Study coordinator: Gretchen C Scott, R.N.
  • Email: SNBrecruiting@nih.gov
  • Phone: (301) 496-2921

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.